BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3499332)

  • 1. Active rosette forming T-lymphocytes in diabetes mellitus.
    Uriarte A; Ventura R; Gabrera E; Perich P
    Exp Clin Endocrinol; 1987 Aug; 89(3):307-11. PubMed ID: 3499332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of T-lymphocyte differentiation in type-1 diabetes mellitus].
    Zhuk EA; Galenok VA
    Ter Arkh; 1995; 67(10):12-5. PubMed ID: 8779094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
    Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
    Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma from insulin-dependent diabetics inhibits theophylline sensitive T-lymphocytes demonstrated in E-rosette assay.
    Buschard K; Madsbad S; Rygaard J
    J Clin Lab Immunol; 1983 Jul; 11(3):123-8. PubMed ID: 6224937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
    Pan CY; Lu JM; Chang XM; Luo GC; Li H
    Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human thymus cells: a study of rosette-forming capacity with unsensitized and sensitized erythrocytes of various species.
    Han T; Diegelman P; Subramanian S; Minowada J
    Immunology; 1979 Nov; 38(3):585-90. PubMed ID: 316414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
    Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of wound healing in patients with diabetes mellitus].
    Kim AIu; Morozov IuI; Kirdeĭ EG
    Klin Med (Mosk); 1994; 72(6):48-50. PubMed ID: 7898011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS; Kyner JL; Abdou NI
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
    Babusíková O; Babusík P; Novotná L
    Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of E-rosette-forming lymphocytes in aged subjects with Taichiquan exercise.
    Sun XS; Xu Y; Xia YJ
    Int J Sports Med; 1989 Jun; 10(3):217-9. PubMed ID: 2789200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The demonstration and specificity of autoreactive T-lymphocytes in type-1 diabetes].
    Lohmann T; Scherbaum WA
    Dtsch Med Wochenschr; 1997 Jun; 122(23):737-42. PubMed ID: 9229550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
    Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
    Spooren PF; Vermes I; Soons JW
    Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
    Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
    Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosette formation with mouse erythrocytes by lymphocytes from normal donors and patients with various diseases.
    Pandolfi F; Paganelli R; Sirianni MC; D'Amelio R; Aiuti F
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):378-86. PubMed ID: 314205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.